{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:27:02Z","timestamp":1793932022810,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.xkme.2026.101451","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:42:01Z","timestamp":1782258121000},"page":"101451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT): A Multicenter Randomized Blinded Placebo Controlled Crossover Trial"],"prefix":"10.1016","volume":"8","author":[{"given":"David","family":"Collister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio Ayala","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Cherepak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun Fu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Girimonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xkme.2026.101451_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.ackd.2006.10.001","article-title":"The prevalence of symptoms in end-stage renal disease: a systematic review","volume":"14","author":"Murtagh","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"10.1016\/j.xkme.2026.101451_bib2","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","article-title":"Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"21","author":"Pisoni","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11136-011-9964-x","article-title":"Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form","volume":"21","author":"Lopes","year":"2012","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ki.2013.454","article-title":"Uremic pruritus","volume":"87","author":"Mettang","year":"2015","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","article-title":"Clinical classification of itch: a position paper of the International Forum for the Study of Itch","volume":"87","author":"St\u00e4nder","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ndt\/gfac226","article-title":"Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study","volume":"38","author":"Collister","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpainsymman.2020.08.003","article-title":"Nephrologist views regarding cannabinoid use in advanced chronic kidney disease and dialysis: a survey","volume":"61","author":"Collister","year":"2021","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10.1016\/j.xkme.2026.101451_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2215\/CJN.11560821","article-title":"Cannabinoids for symptom management in patients with kidney failure: a narrative review","volume":"17","author":"Worth","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101451_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/2054358119828391","article-title":"A review of cannabis in chronic kidney disease symptom management","volume":"6","author":"Ho","year":"2019","journal-title":"Can J Kidney Health Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","article-title":"Treatment of uremic pruritus: a systematic review","volume":"70","author":"Simonsen","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MNH.0000000000000625","article-title":"Recent advances in the treatment of uremic pruritus","volume":"29","author":"Trachtenberg","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"12","key":"10.1016\/j.xkme.2026.101451_bib14","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2215\/CJN.03280317","article-title":"International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis","volume":"12","author":"Rayner","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101451_bib15","article-title":"Interventions for itch in people with advanced chronic kidney disease","volume":"12","author":"Hercz","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.xkme.2026.101451_bib16","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1681\/ASN.2018010096","article-title":"Gabapentin and pregabalin use and association with adverse outcomes among hemodialysis patients","volume":"29","author":"Ishida","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2026.101451_bib17","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2215\/CJN.01610214","article-title":"Setting research priorities for patients on or nearing dialysis","volume":"9","author":"Manns","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.xkme.2026.101451_bib19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2215\/CJN.00100110","article-title":"A longitudinal study of uremic pruritus in hemodialysis patients","volume":"5","author":"Mathur","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40262-014-0195-5","article-title":"Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics","volume":"54","author":"Heuberger","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xkme.2026.101451_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/2054358117749530","article-title":"Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): form and function","volume":"5","author":"Levin","year":"2018","journal-title":"Can J Kidney Health Dis"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib23","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2340\/00015555-1265","article-title":"Visual analogue scale: evaluation of the instrument for the assessment of pruritus","volume":"92","author":"Reich","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2340\/00015555-1246","article-title":"Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus","volume":"92","author":"Phan","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib25","first-page":"997","article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jid.2021.06.032","article-title":"Measurement properties of patient-reported outcome measures for pruritus: an updated systematic review","volume":"142","author":"Topp","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101451_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5L: a systematic review of the literature","volume":"30","author":"Feng","year":"2021","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jaad.2020.01.036","article-title":"Cannabinoids for the treatment of chronic pruritus: a review","volume":"82","author":"Avila","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.xkme.2026.101451_bib31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2340\/00015555-2433","article-title":"Itch assessment with visual analogue scale and numerical rating scale: determination of minimal clinically important difference in chronic itch","volume":"96","author":"Reich","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101451_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A phase 3 trial of difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.ajkd.2022.10.015","article-title":"Sex and gender in randomized controlled trials of adults receiving maintenance dialysis: a meta-epidemiologic study","volume":"81","author":"Collister","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.xkme.2026.101451_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2288-3-22","article-title":"How many repeated measures in repeated measures designs? Statistical issues for comparative trials","volume":"3","author":"Vickers","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.xkme.2026.101451_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120954024","article-title":"Have we just scratched the surface? A narrative review of uremic pruritus in 2020","volume":"7","author":"Martin","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.xkme.2026.101451_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.xkme.2026.101451_bib37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1191\/1740774504cn004rr","article-title":"Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials","volume":"1","author":"Sydes","year":"2004","journal-title":"Clin Trials"},{"issue":"2","key":"10.1016\/j.xkme.2026.101451_bib38","first-page":"97","article-title":"Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study","volume":"13","author":"Szepietowski","year":"2005","journal-title":"Acta Dermatovenerol Croat"},{"issue":"10","key":"10.1016\/j.xkme.2026.101451_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100894","article-title":"Cannabis-containing cream for CKD-associated pruritus: a double-blind, placebo controlled trial","volume":"6","author":"Anumas","year":"2024","journal-title":"Kidney Med"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.17744","article-title":"Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis","volume":"181","author":"Yosipovitch","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.05490610","article-title":"Randomized, double-blind study with glycerol and paraffin in uremic xerosis","volume":"6","author":"Balaskas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib42","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/jid.2014.522","article-title":"Placebo effects on itch: a meta-analysis of clinical trials of patients with dermatological conditions","volume":"135","author":"van Laarhoven","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.xkme.2026.101451_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40261-020-00894-7","article-title":"Mechanisms of cannabinoids and potential applicability to skin diseases","volume":"40","author":"Cintosun","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.xkme.2026.101451_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bcp.2018.08.022","article-title":"The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders","volume":"157","author":"R\u00edo","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"5-6","key":"10.1016\/j.xkme.2026.101451_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.lfs.2010.06.003","article-title":"Effects of cannabinoids on capsaicin receptor activity following exposure of primary sensory neurons to inflammatory mediators","volume":"87","author":"Soneji","year":"2010","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.xkme.2026.101451_bib46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ndt\/gfi204","article-title":"The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients","volume":"21","author":"Kimmel","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2026.101451_bib47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12916-022-02459-1","article-title":"Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications","volume":"20","author":"Bilbao","year":"2022","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101451_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/j.ajkd.2023.09.012","article-title":"Kidney function decline and serious adverse drug reactions in patients with CKD","volume":"83","author":"Laville","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.xkme.2026.101451_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41581-021-00518-z","article-title":"Patient-centred approaches for the management of unpleasant symptoms in kidney disease","volume":"18","author":"Kalantar-Zadeh","year":"2022","journal-title":"Nat Rev Nephrol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952600213X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952600213X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:34:56Z","timestamp":1793928896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952600213X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S259005952600213X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101451","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT): A Multicenter Randomized Blinded Placebo Controlled Crossover Trial","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101451"}}